| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |